Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Genprex, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2025
- Shares held
- 7.16K
- −1.35M (−99.5%) vs. Q3 2025
- Total value
- $13.0K
- −$216.5K (−94.3%) vs. Q3 2025
- New holders
- 7
- 0 more added
- Sold out
- 6
- 15 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,280 | $5.74K | 0.00% | −2,528−43.5% | Reduced |
| Cheviot Value Management, LLC | 1,000 | $2.22K | 0.00% | +1,000 | New |
| Miller Wealth Advisors, LLC | 1,200 | $2.10K | 0.00% | +1,200 | New |
| Jones Financial Companies LLLP | 1,055 | $1.85K | 0.00% | +1,055 | New |
| Advisor Group Holdings, Inc. | 232 | $404 | 0.00% | −8,378−97.3% | Reduced |
| BlackRock, Inc. | 188 | $329 | 0.00% | −9,203−98.0% | Reduced |
| UBS Group AG | 94 | $165 | 0.00% | −162,108−99.9% | Reduced |
| SBI Securities Co., Ltd. | 48 | $84 | 0.00% | −2,373−98.0% | Reduced |
| Bank of America Corp | 18 | $31 | 0.00% | −697−97.5% | Reduced |
| HighMark Wealth Management LLC | 10 | $17 | 0.00% | −490−98.0% | Reduced |
| Morgan Stanley | 6 | $11 | 0.00% | −952−99.4% | Reduced |
| Nemes Rush Group LLC | 5 | $9 | 0.00% | −245−98.0% | Reduced |
| Citigroup Inc | 4 | $7 | 0.00% | −6,080−99.9% | Reduced |
| Allworth Financial LP | 3 | $6 | 0.00% | −122−97.6% | Reduced |
| FMR LLC | 3 | $5 | 0.00% | +3 | New |
| Group One Trading, L.P. | 2 | $4 | 0.00% | −22−91.7% | Reduced |
| JPMorgan Chase & Co | 2 | $4 | 0.00% | −3−60.0% | Reduced |
| Global Retirement Partners, LLC | 1 | $2 | 0.00% | −4−80.0% | Reduced |
| Danske Bank A/S | 1 | $2 | 0.00% | +1 | New |
| Curio Wealth, LLC | 1 | $2 | 0.00% | +1 | New |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% | −24−96.0% | Reduced |
| Motiv8 Investments LLC | 1 | $0 | 0.00% | +1 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −433,369−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −340,056−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −205,180−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −164,027−100.0% | Sold out |
| TCG Advisory Services, LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −63−100.0% | Sold out |